help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bellido, T.
Right arrow Articles by Manolagas, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bellido, T.
Right arrow Articles by Manolagas, S. C.
Endocrinology Vol. 138, No. 9 3666-3676
Copyright © 1997 by The Endocrine Society

ARTICLES

Activation of the Janus Kinase/STAT (Signal Transducer and Activator of Transcription) Signal Transduction Pathway by Interleukin-6-Type Cytokines Promotes Osteoblast Differentiation1

Teresita Bellido, Victoria Z. C. Borba, Paula Roberson and Stavros C. Manolagas

Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and the McClellan Veterans Administration Medical Center, Geriatric Research, Education, and Clinical Center, Little Rock, Arkansas 72205

Address all correspondence and requests for reprints to: Teresita Bellido, Ph.D., Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences, 4301 West Markham, Mail Slot 587, Little Rock, Arkansas 72205. E-mail: TMBELLIDO{at}LIFE.UAMS.EDU

We have previously established that stromal/osteoblastic cells collectively express receptors for all members of the cytokine subfamily that share the gp130 signal transducer and that different receptor repertoires may be expressed at different stages of differentiation of this lineage. We have now used human (MG-63) and murine (MC3T3-E1) osteoblastic cell lines as well as primary murine calvaria cells to test the hypothesis that these receptors mediate effects of the cytokines on the biology of osteoblasts. We report that as in other cell types, all of the osteoblastic cell models responded to interleukin-6 (IL-6)-type cytokines with activation of both the JAK/STAT (Janus kinase/signal transducer and activator of transcription) and the mitogen-activated protein kinase (MAPK) pathways. In addition, IL-6-type cytokines stimulated alkaline phosphatase activity and osteocalcin expression and inhibited (MG-63), stimulated (MC3T3-E1), or had no effect (calvaria cells) on the rate of cell proliferation. The ability of a given cell type to respond to a particular member of this family of cytokines was strictly dependent on the presence of the corresponding ligand-binding subunit ({alpha}) of the cytokine receptor, and the magnitude of all the effects was closely correlated with the concentration of this subunit. The relative contribution of the JAK/STAT and MAPK pathways to the biological effects of the cytokines was evaluated using kinase inhibitors. Cytokine-mediated modulation of cell proliferation as well as stimulation of alkaline phosphatase activity were abrogated by tyrosine kinase inhibitors as well as a threonine/serine kinase inhibitor, but were only minimally affected by a specific inhibitor of MAPK phosphorylation. These results demonstrate that IL-6-type cytokines, besides their osteoclastogenic properties, promote differentiation of committed osteoblastic cells toward a more mature phenotype and that this action is mediated primarily via the activation of the JAK/STAT pathway.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
G. Deng, S. Kakar, K. Okudiara, E. Choi, M. H. Sleisenger, and Y. S. Kim
Unique Methylation Pattern of Oncostatin M Receptor Gene in Cancers of Colorectum and Other Digestive Organs
Clin. Cancer Res., March 1, 2009; 15(5): 1519 - 1526.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
K. Iwasaki, M. Komaki, K. Mimori, E. Leon, Y. Izumi, and I. Ishikawa
IL-6 Induces Osteoblastic Differentiation of Periodontal Ligament Cells
Journal of Dental Research, October 1, 2008; 87(10): 937 - 942.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z. Li, M. Q. Hassan, S. Volinia, A. J. van Wijnen, J. L. Stein, C. M. Croce, J. B. Lian, and G. S. Stein
A microRNA signature for a BMP2-induced osteoblast lineage commitment program
PNAS, September 16, 2008; 105(37): 13906 - 13911.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. Brounais, C. Chipoy, K. Mori, C. Charrier, S. Battaglia, P. Pilet, C. D. Richards, D. Heymann, F. Redini, and F. Blanchard
Oncostatin M Induces Bone Loss and Sensitizes Rat Osteosarcoma to the Antitumor Effect of Midostaurin In vivo
Clin. Cancer Res., September 1, 2008; 14(17): 5400 - 5409.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. I. Plotkin, J. I. Aguirre, S. Kousteni, S. C. Manolagas, and T. Bellido
Bisphosphonates and Estrogens Inhibit Osteocyte Apoptosis via Distinct Molecular Mechanisms Downstream of Extracellular Signal-regulated Kinase Activation
J. Biol. Chem., February 25, 2005; 280(8): 7317 - 7325.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. M. Kennedy, K. L. Shogren, M. Zhang, R. T. Turner, T. C. Spelsberg, and A. Maran
17{beta}-Estradiol-Dependent Activation of Signal Transducer and Activator of Transcription-1 in Human Fetal Osteoblasts Is Dependent on Src Kinase Activity
Endocrinology, January 1, 2005; 146(1): 201 - 207.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Xiao, T. Naganawa, E. Obugunde, G. Gronowicz, D. M. Ornitz, J. D. Coffin, and M. M. Hurley
Stat1 Controls Postnatal Bone Formation by Regulating Fibroblast Growth Factor Signaling in Osteoblasts
J. Biol. Chem., June 25, 2004; 279(26): 27743 - 27752.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H.-I. Shin, P. Divieti, N. A. Sims, T. Kobayashi, D. Miao, A. C. Karaplis, R. Baron, R. Bringhurst, and H. M. Kronenberg
gp130-Mediated Signaling Is Necessary for Normal Osteoblastic Function in Vivo and in Vitro
Endocrinology, March 1, 2004; 145(3): 1376 - 1385.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
S. Kim, T. Koga, M. Isobe, B. E. Kern, T. Yokochi, Y. E. Chin, G. Karsenty, T. Taniguchi, and H. Takayanagi
Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation
Genes & Dev., August 15, 2003; 17(16): 1979 - 1991.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Legendre, J. Dudhia, J.-P. Pujol, and P. Bogdanowicz
JAK/STAT but Not ERK1/ERK2 Pathway Mediates Interleukin (IL)-6/Soluble IL-6R Down-regulation of Type II Collagen, Aggrecan Core, and Link Protein Transcription in Articular Chondrocytes. ASSOCIATION WITH A DOWN-REGULATION OF SOX9 EXPRESSION
J. Biol. Chem., January 24, 2003; 278(5): 2903 - 2912.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Vermes, J. J. Jacobs, J. Zhang, G. Firneisz, K. A. Roebuck, and T. T. Glant
Shedding of the Interleukin-6 (IL-6) Receptor (gp80) Determines the Ability of IL-6 to Induce gp130 Phosphorylation in Human Osteoblasts
J. Biol. Chem., May 3, 2002; 277(19): 16879 - 16887.
[Abstract] [Full Text] [PDF]

Home page
 Recent Prog Horm ResHome page
S.C. Manolagas, S. Kousteni, and R.L. Jilka
Sex Steroids and Bone
Recent Prog. Horm. Res., January 1, 2002; 57(1): 385 - 409.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. A. Karsdal, M. S. Fjording, N. T. Foged, J.-M. Delaisse, and A. Lochter
Transforming Growth Factor-beta -induced Osteoblast Elongation Regulates Osteoclastic Bone Resorption through a p38 Mitogen-activated Protein Kinase- and Matrix Metalloproteinase-dependent Pathway
J. Biol. Chem., October 12, 2001; 276(42): 39350 - 39358.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. J. Auernhammer and S. Melmed
Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function
Endocr. Rev., June 1, 2000; 21(3): 313 - 345.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
S. C. Manolagas
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis
Endocr. Rev., April 1, 2000; 21(2): 115 - 137.
[Abstract] [Full Text]

Home page
 JCBHome page
O. A. Adebanjo, B. S. Moonga, T. Yamate, L. Sun, C. Minkin, E. Abe, and M. Zaidi
Mode of Action of Interleukin-6 on Mature Osteoclasts. Novel Interactions with Extracellular Ca2+ Sensing in the Regulation of Osteoclastic Bone Resorption
J. Cell Biol., September 7, 1998; 142(5): 1347 - 1356.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Bellido, C. A. O'Brien, P. K. Roberson, and S. C. Manolagas
Transcriptional Activation of the p21WAF1,CIP1,SDI1 Gene by Interleukin-6 Type Cytokines. A PREREQUISITE FOR THEIR PRO-DIFFERENTIATING AND ANTI-APOPTOTIC EFFECTS ON HUMAN OSTEOBLASTIC CELLS
J. Biol. Chem., August 14, 1998; 273(33): 21137 - 21144.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Bellido, M. Huening, M. Raval-Pandya, S. C. Manolagas, and S. Christakos
Calbindin-D28k Is Expressed in Osteoblastic Cells and Suppresses Their Apoptosis by Inhibiting Caspase-3 Activity
J. Biol. Chem., August 18, 2000; 275(34): 26328 - 26332.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society